THE CLINICAL EFFECTS OF COVID-19 ON LIVER ENZYMES AND FERRITIN PROTEIN LEVEL IN IRAQI PATIENTS

Abstract

In 2019 has seen a lot of critical attention focused on patients with coronavirus illness who have liver damage. However, it is unclear whether the presence of a high rate of liver enzymes is a result of the viral infection or the underlying undetected liver illness. From July 2020 to September 2021, we used polymerase chain reaction to retrospectively investigate 1280 patients who had SARS-CoV-2 at our particular medical facility. The 48 hours following admission were used to acquire all laboratory tests. In the cities of Baghdad and Al-Basrah, patients hospitalized with COVID-19 disease had a notably high rate of liver impairment. More patients who had liver failure and high ferritin protein levels at the time of their admission needed intensive care and mechanical ventilation.